A Safe Transitions Pathway for post-craniotomy neurological surgery patients: high-value care that bypasses the intensive care unit.


Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
29 May 2020
Historique:
received: 08 08 2019
accepted: 11 03 2020
pubmed: 30 5 2020
medline: 10 8 2021
entrez: 30 5 2020
Statut: epublish

Résumé

High-value medical care is described as care that leads to excellent patient outcomes, high patient satisfaction, and efficient costs. Neurosurgical care in particular can be expensive for the hospital, as substantial costs are accrued during the operation and throughout the postoperative stay. The authors developed a "Safe Transitions Pathway" (STP) model in which select patients went to the postanesthesia care unit (PACU) and then the neuro-transitional care unit (NTCU) rather than being directly admitted to the neurosciences intensive care unit (ICU) following a craniotomy. They sought to evaluate the clinical and financial outcomes as well as the impact on the patient experience for patients who participated in the STP and bypassed the ICU level of care. Patients were enrolled during the 2018 fiscal year (FY18; July 1, 2017, through June 30, 2018). The electronic medical record was reviewed for clinical information and the hospital cost accounting record was reviewed for financial information. Nurses and patients were given a satisfaction survey to assess their respective impressions of the hospital stay and of the recovery pathway. No patients who proceeded to the NTCU postoperatively were upgraded to the ICU level of care postoperatively. There were no deaths in the STP group, and no patients required a return to the operating room during their hospitalization (95% CI 0%-3.9%). There was a trend toward fewer 30-day readmissions in the STP patients than in the standard pathway patients (1.2% [95% CI 0.0%-6.8%] vs 5.1% [95% CI 2.5%-9.1%], p = 0.058). The mean number of ICU days saved per case was 1.20. The average postprocedure length of stay was reduced by 0.25 days for STP patients. Actual FY18 direct cost savings from 94 patients who went through the STP was $422,128. Length of stay, direct cost per case, and ICU days were significantly less after the adoption of the STP, and ICU bed utilization was freed for acute admissions and transfers. There were no substantial complications or adverse patient outcomes in the STP group.

Identifiants

pubmed: 32470928
doi: 10.3171/2020.3.JNS192133
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1386-1391

Auteurs

Jacob S Young (JS)

1Department of Neurological Surgery and.

Andrew K Chan (AK)

1Department of Neurological Surgery and.

Jennifer A Viner (JA)

1Department of Neurological Surgery and.

Sujatha Sankaran (S)

2Division of Hospital Medicine, Department of Medicine, University of California, San Francisco.

Alvin Y Chan (AY)

3Department of Neurological Surgery, University of California, Irvine.

Sarah Imershein (S)

4University of California San Francisco Medical Center, San Francisco; and.

Aldea Meary-Miller (A)

4University of California San Francisco Medical Center, San Francisco; and.

Philip V Theodosopoulos (PV)

1Department of Neurological Surgery and.

Line Jacques (L)

1Department of Neurological Surgery and.

Manish K Aghi (MK)

1Department of Neurological Surgery and.

Edward F Chang (EF)

1Department of Neurological Surgery and.

Shawn L Hervey-Jumper (SL)

1Department of Neurological Surgery and.

Tracy Ward (T)

1Department of Neurological Surgery and.

Liz Gibson (L)

1Department of Neurological Surgery and.

Mariann M Ward (MM)

1Department of Neurological Surgery and.

Peter Sanftner (P)

1Department of Neurological Surgery and.

Stacy Wong (S)

1Department of Neurological Surgery and.

Dominic Amara (D)

5School of Medicine, University of California, San Francisco, California.

Stephen T Magill (ST)

1Department of Neurological Surgery and.

Joseph A Osorio (JA)

1Department of Neurological Surgery and.

Brinda Venkatesh (B)

4University of California San Francisco Medical Center, San Francisco; and.

Ralph Gonzales (R)

5School of Medicine, University of California, San Francisco, California.

Catherine Lau (C)

2Division of Hospital Medicine, Department of Medicine, University of California, San Francisco.

Christy Boscardin (C)

5School of Medicine, University of California, San Francisco, California.

Michael Wang (M)

4University of California San Francisco Medical Center, San Francisco; and.

Kim Berry (K)

4University of California San Francisco Medical Center, San Francisco; and.

Laurie McCullagh (L)

4University of California San Francisco Medical Center, San Francisco; and.

Mary Reid (M)

4University of California San Francisco Medical Center, San Francisco; and.

Kayla Reels (K)

4University of California San Francisco Medical Center, San Francisco; and.

Sara Nedkov (S)

4University of California San Francisco Medical Center, San Francisco; and.

Mitchel S Berger (MS)

1Department of Neurological Surgery and.

Michael W McDermott (MW)

1Department of Neurological Surgery and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH